{"id":"https://openalex.org/W4283320953","doi":"https://doi.org/10.1097/01.hs9.0000845064.44923.05","title":"P544: MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL IN TREATMENT-NA\u00cfVE PATIENTS WITH ACUTE MYELOID LEUKEMIA FOLLOWING VENETOCLAX AND HYPOMETHYLATING AGENTS","display_name":"P544: MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL IN TREATMENT-NA\u00cfVE PATIENTS WITH ACUTE MYELOID LEUKEMIA FOLLOWING VENETOCLAX AND HYPOMETHYLATING AGENTS","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4283320953","doi":"https://doi.org/10.1097/01.hs9.0000845064.44923.05"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000845064.44923.05","doi":"https://doi.org/10.1097/01.hs9.0000845064.44923.05","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000845064.44923.05","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/01.hs9.0000845064.44923.05","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012571611","display_name":"I. Johnson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"I. Johnson","raw_affiliation_strings":["Department of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088240594","display_name":"K. McCullough","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. McCullough","raw_affiliation_strings":["Divison of Hematology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divison of Hematology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053193906","display_name":"F. Farrukh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. Farrukh","raw_affiliation_strings":["Mayo Clinic, Rochester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008422091","display_name":"Aref Al\u2010Kali","orcid":"https://orcid.org/0000-0002-0824-3715","observed_orcids":["https://orcid.org/0000-0002-0824-3715"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Al-Kali","raw_affiliation_strings":["Mayo Clinic, Rochester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064856519","display_name":"Hassan B. Alkhateeb","orcid":"https://orcid.org/0000-0002-3609-8404","observed_orcids":["https://orcid.org/0000-0002-3609-8404"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Alkhateeb","raw_affiliation_strings":["Mayo Clinic, Rochester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080965667","display_name":"Kebede H. Begna","orcid":"https://orcid.org/0000-0003-2730-8593","observed_orcids":["https://orcid.org/0000-0003-2730-8593"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Begna","raw_affiliation_strings":["Mayo Clinic, Rochester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012298768","display_name":"Abhishek Avinash Mangaonkar","orcid":"https://orcid.org/0000-0003-2458-9887","observed_orcids":["https://orcid.org/0000-0003-2458-9887"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Mangaonkar","raw_affiliation_strings":["Mayo Clinic, Rochester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085360755","display_name":"Mark Robert Litzow","orcid":"https://orcid.org/0000-0002-9816-6302","observed_orcids":["https://orcid.org/0000-0002-9816-6302"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Litzow","raw_affiliation_strings":["Mayo Clinic, Rochester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084606047","display_name":"William J. Hogan","orcid":"https://orcid.org/0000-0002-5841-4105","observed_orcids":["https://orcid.org/0000-0002-5841-4105"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Hogan","raw_affiliation_strings":["Mayo Clinic, Rochester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Shah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Shah","raw_affiliation_strings":["Mayo Clinic, Rochester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072463255","display_name":"Mrinal M. Patnaik","orcid":"https://orcid.org/0000-0001-6998-662X","observed_orcids":["https://orcid.org/0000-0001-6998-662X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Patnaik","raw_affiliation_strings":["Mayo Clinic, Rochester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024612499","display_name":"Animesh Dev Pardanani","orcid":"https://orcid.org/0000-0002-9084-4148","observed_orcids":["https://orcid.org/0000-0002-9084-4148"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Pardanani","raw_affiliation_strings":["Mayo Clinic, Rochester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016216479","display_name":"Ayalew Tefferi","orcid":"https://orcid.org/0000-0003-4605-3821","observed_orcids":["https://orcid.org/0000-0003-4605-3821"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Tefferi","raw_affiliation_strings":["Mayo Clinic, Rochester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002643270","display_name":"Naseema Gangat","orcid":"https://orcid.org/0000-0002-9104-6172","observed_orcids":["https://orcid.org/0000-0002-9104-6172"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Gangat","raw_affiliation_strings":["Mayo Clinic, Rochester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5012571611"],"corresponding_institution_ids":[],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":null,"first_page":"443","last_page":"444"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9700000286102295},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.996999979019165},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.9990000128746033},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.7229999899864197},{"id":"https://openalex.org/keywords/molecular-predictors","display_name":"molecular predictors","score":0.5830000042915344},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.8920000195503235},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6669999957084656},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.7820000052452087},{"id":"https://openalex.org/keywords/npm1-mutation","display_name":"NPM1 mutation","score":0.753000020980835},{"id":"https://openalex.org/keywords/dnmt3a-mutation","display_name":"DNMT3A mutation","score":0.8700000047683716},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.8949999809265137},{"id":"https://openalex.org/keywords/idh2-mutation","display_name":"IDH2 mutation","score":0.5870000123977661},{"id":"https://openalex.org/keywords/asxl1","display_name":"ASXL1","score":0.6309999823570251},{"id":"https://openalex.org/keywords/srsf2","display_name":"SRSF2","score":0.7269999980926514},{"id":"https://openalex.org/keywords/tet2","display_name":"TET2","score":0.7480000257492065},{"id":"https://openalex.org/keywords/prognostic-mutations","display_name":"prognostic mutations","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8285126686096191},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7233432531356812},{"id":"https://openalex.org/C2483381","wikidata":"https://www.wikidata.org/wiki/Q18030194","display_name":"NPM1","level":5,"score":0.712260901927948},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.6706282496452332},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.5345325469970703},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.5125955939292908},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47688180208206177},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.45616087317466736},{"id":"https://openalex.org/C127848430","wikidata":"https://www.wikidata.org/wiki/Q18027543","display_name":"IDH1","level":4,"score":0.4424522817134857},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.42861711978912354},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.390893816947937},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.333465039730072},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.1762388050556183},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.09537160396575928},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.07534363865852356},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C30481170","wikidata":"https://www.wikidata.org/wiki/Q37748","display_name":"Chromosome","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C53226629","wikidata":"https://www.wikidata.org/wiki/Q189967","display_name":"Karyotype","level":4,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1097/01.hs9.0000845064.44923.05","doi":"https://doi.org/10.1097/01.hs9.0000845064.44923.05","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000845064.44923.05","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:1c4c0a7f80514325baada8e1d78125c3","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/1c4c0a7f80514325baada8e1d78125c3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 6, Pp 443-444 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000845064.44923.05","doi":"https://doi.org/10.1097/01.hs9.0000845064.44923.05","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000845064.44923.05","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389247510","https://openalex.org/W4310127695","https://openalex.org/W4389521337","https://openalex.org/W3080879632","https://openalex.org/W4405051302","https://openalex.org/W7204715989","https://openalex.org/W4417014968","https://openalex.org/W4407411233","https://openalex.org/W4405041434","https://openalex.org/W4286295738"],"abstract_inverted_index":{"Background:":[0],"Venetoclax":[1],"(Ven)":[2],"in":[3,74,160,165,169,173,177,181,185,189,193,197,221,223,311,328,406,417],"combination":[4],"with":[5,34,40,48,215,236],"hypomethylating":[6],"agents":[7],"(HMA)":[8],"is":[9],"FDA-approved":[10],"for":[11,444],"elderly/unfit":[12],"AML":[13,76,82,129,245],"patients.":[14,200,226],"Limited":[15],"data":[16],"exists":[17],"on":[18,70,529],"molecular":[19],"predictors":[20,516],"of":[21,68,203,231,258,282,292,321,333,344,377,384,466,494,505,510,517],"response":[22,29,71,204,238,304,338],"and":[23,45,50,72,264,290,299,390,404,432,472,508,512,533],"survival.":[24,445],"In":[25,227,274],"a":[26,87,380,476,523],"prior":[27],"study,":[28],"was":[30,63,104,234,316,401,479],"superior":[31],"(CR/CRi":[32,239,246],">80%)":[33],"NPM1,":[35],"IDH1/2,":[36],"DNMT3A":[37,192,356],"mutations,":[38],"inferior":[39,272,337],"TP53,":[41],"RUNX1,":[42],"FLT3/ITD,":[43],"RAS":[44,366],"prolonged":[46],"survival":[47,73,378,399,464,526],"NPM1":[49,188,345,425],"IDH2":[51],"mutations":[52,69,266,301,428,436,514],"(2":[53],"yr":[54],"OS":[55],"71.8%/79.5%)":[56],"(DiNardo,":[57],"Blood,":[58],"2020).":[59,499],"Aims:":[60],"Our":[61,489],"objective":[62],"to":[64,107,456],"determine":[65],"the":[66,91,108,278,462,483],"impact":[67,373,465],"treatment-na\u00efve":[75],"patients":[77,83,130,162,207,388,408,419,451],"receiving":[78,84],"Ven+HMA.":[79,142],"Methods:":[80],"Treatment-na\u00efve":[81],"Ven+HMA":[85],"outside":[86],"clinical":[88],"trial":[89],"at":[90],"Mayo":[92],"Clinic":[93],"were":[94,98,117],"included.":[95],"Molecular":[96],"studies":[97],"performed":[99,118],"by":[100,319,481],"next-generation":[101],"sequencing.":[102],"Response":[103],"assessed":[105],"according":[106],"2017":[109],"European":[110],"LeukemiaNet":[111],"(ELN)":[112],"criteria.":[113],"Standard":[114],"statistical":[115],"analyses":[116],"using":[119,482],"JMP":[120],"Pro":[121],"(Version":[122],"16.0.0).":[123],"Results:":[124],"i)":[125],"Patient":[126],"characteristics":[127],"103":[128],"(median":[131],"age":[132],"74":[133],"years,":[134],"67%":[135],"male,":[136],"62%":[137],"de":[138],"novo)":[139],"received":[140],"upfront":[141],"ELN":[143],"cytogenetic":[144],"risk":[145,442],"included":[146],"favorable":[147,237,303,518],"(6%,":[148],"n=6),":[149],"intermediate":[150],"(50%,":[151],"n=52)":[152],"or":[153],"adverse":[154,251,438,473],"(44%,":[155],"n=45).":[156],"Mutations":[157],"involved":[158],"TP53":[159,259,293,322,334,433,511],"25":[161],"(25%),":[163],"TET2":[164],"24":[166],"(23%),":[167],"IDH1/IDH2":[168],"20":[170,212],"(19%),":[171,175],"RUNX1":[172,361],"19":[174],"ASXL1":[176,232,283,312,329,435,449,470,506,531],"18":[178,182],"(18%),),":[179],"SRSF2":[180],"(18%),":[183],"K/NRAS":[184],"15":[186],"(15%),":[187],"13":[190,194],"(13%),":[191,195],"FLT3-ITD":[196,265,300,513],"10":[198],"(10%)":[199],"ii)":[201],"Predictors":[202,376],"40":[205],"(39%)":[206],"achieved":[208],"complete":[209],"remission":[210],"(CR),":[211],"(19%)":[213],"CR":[214],"incomplete":[216],"hematological":[217],"recovery":[218],"(CRi),":[219],"resulting":[220],"CR/CRi":[222,315,423],"60":[224],"(58%)":[225],"univariate":[228],"analysis,":[229,276],"presence":[230,257,281,320,332,504],"mutation":[233,284,323,335,471,507,532],"associated":[235],"83%":[240],"vs":[241,248,254,261,268,286,295,306,325,340,348,353,358,363,368,411],"53%,":[242],"p=0.01),":[243],"secondary":[244],"49%":[247],"65%,":[249],"p=0.09),":[250],"karyotype":[252,439],"(49%":[253],"67%,":[255,262],"p=0.11),":[256],"(32%":[260],"p=0.002)":[263],"(30%":[267],"61%;":[269],"p=0.06)":[270],"predicted":[271,302,336],"response.":[273,374,519],"multivariable":[275],"including":[277],"aforementioned":[279],"variables,":[280],"(83%":[285],"53%;":[287],"OR":[288,297,308],"4.5)":[289],"absence":[291,509],"(67%":[294],"32%;":[296],"3.3)":[298],"(61%":[305],"30%;":[307],"6.4).":[309],"Moreover,":[310],"mutated":[313,450],"patients,":[314,331],"not":[317,372,420,467],"impacted":[318],"(100%":[324],"81%)":[326],"whereas":[327],"unmutated":[330],"(26%":[339],"63%;":[341],"p=0.001).":[342],"Presence":[343],"(CR/CRi;":[346],"69%":[347],"57%,":[349],"p=0.41),":[350],"IDH1/2":[351,427],"(70%":[352],"55%;":[354],"p=0.23),":[355],"(54%":[357],"59%;":[359],"p=0.73),":[360],"(58%":[362],"58%;":[364],"p=0.1),":[365],"(60%":[367],"58%,":[369],"p=0.88)":[370],"did":[371],"iii)":[375],"After":[379],"median":[381],"follow":[382],"up":[383],"6.6":[385],"months,":[386,413],"68":[387],"died":[389],"9":[391],"underwent":[392],"allogeneic":[393],"stem":[394],"cell":[395],"transplant.":[396],"Median":[397],"overall":[398],"(mOS)":[400],"8.5":[402],"months":[403],"longer":[405],"transplanted":[407],"(not":[409],"reached":[410],"8.4":[412],"p=0.08).":[414],"Age-adjusted":[415],"analysis":[416,460],"94":[418],"transplanted,":[421],"identified":[422],"(p<0.0001),":[424],"(p=0.009),":[426],"(p=0.02)":[429],"as":[430,515],"favorable,":[431],"(p=0.01),":[434],"(p=0.17)":[437],"(p=0.05)":[440],"unfavorable":[441],"factors":[443],"Despite":[446],"higher":[447,457],"CR/CRi,":[448,469],"had":[452],"shortened":[453],"mOS":[454],"due":[455],"relapse.":[458],"Multivariable":[459],"confirmed":[461],"negative":[463],"achieving":[468],"karyotype.":[474,534],"Accordingly,":[475],"three-tiered":[477,525],"model":[478,527],"generated":[480],"three":[484],"variables":[485],"(Figure":[486],"1).":[487],"Image:Summary/Conclusion:":[488],"observations":[490],"differ":[491],"from":[492],"those":[493],"DiNardo,":[495],"et":[496],"al.":[497],"(Blood,":[498],"The":[500],"current":[501],"study":[502],"identifies":[503],"Additionally,":[520],"we":[521],"propose":[522],"novel":[524],"based":[528],"response,":[530]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2022-06-24T00:00:00"}